Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Bone Density in Anorexia Nervosa
NCT03292146Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2017
- Primary completion
- Jul 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab in osteopenia, sponsored by Massachusetts General Hospital. Started Oct 2017; status: completed.
02
Drugs
denosumab
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT03292146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03292146.